{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:56:41Z","timestamp":1787961401347,"version":"build-2784847793"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Research foundation of South Africa","award":["106052"],"award-info":[{"award-number":["106052"]}]},{"name":"National Research Foundation of South Africa","award":["120719"],"award-info":[{"award-number":["120719"]}]},{"name":"National Research Foundation of South Africa","award":["129249"],"award-info":[{"award-number":["129249"]}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["Self-Initiated Research Grant"],"award-info":[{"award-number":["Self-Initiated Research Grant"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004513","name":"Harry Crossley Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s12035-021-02516-5","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T23:08:19Z","timestamp":1629760099000},"page":"5920-5936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, \u03b1-Synuclein and Neuromelanin in Parkinson\u2019s Disease and Intervention with Turmeric"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4219-5139","authenticated-orcid":false,"given":"Zun\u00e9","family":"Jansen van Rensburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1120-678X","authenticated-orcid":false,"given":"Shameemah","family":"Abrahams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3508-3438","authenticated-orcid":false,"given":"Soraya","family":"Bardien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1590-7230","authenticated-orcid":false,"given":"Colin","family":"Kenyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"key":"2516_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Elbaz A, Nichols E et al (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"2516_CR2","doi-asserted-by":"publisher","first-page":"S450","DOI":"10.1016\/S1353-8020(08)70048-8","volume":"13","author":"S Muzerengi","year":"2007","unstructured":"Muzerengi S, Contrafatto D, Chaudhuri KR (2007) Non-motor symptoms: identification and management. Parkinsonism Relat Disord 13:S450\u2013S456. https:\/\/doi.org\/10.1016\/S1353-8020(08)70048-8","journal-title":"Parkinsonism Relat Disord"},{"key":"2516_CR3","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1111\/febs.12335","volume":"280","author":"PMA Antony","year":"2013","unstructured":"Antony PMA, Diederich NJ, Kr\u00fcger R, Balling R (2013) The hallmarks of Parkinson\u2019s disease. FEBS J 280:5981\u20135993. https:\/\/doi.org\/10.1111\/febs.12335","journal-title":"FEBS J"},{"key":"2516_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF00688674","volume":"34","author":"LS Forno","year":"1976","unstructured":"Forno LS, Norville RL (1976) Ultrastructure of Lewy bodies in the stellate ganglion. Acta Neuropathol (Berl) 34:183\u2013197. https:\/\/doi.org\/10.1007\/BF00688674","journal-title":"Acta Neuropathol (Berl)"},{"key":"2516_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1006\/exnr.2000.7527","volume":"166","author":"WP Gai","year":"2000","unstructured":"Gai WP, Yuan HX, Li XQ et al (2000) In situ and in vitro study of colocalization and segregation of \u03b1-synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neurol 166:324\u2013333. https:\/\/doi.org\/10.1006\/exnr.2000.7527","journal-title":"Exp Neurol"},{"key":"2516_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1750-3639.2007.00048.x","volume":"17","author":"JB Leverenz","year":"2007","unstructured":"Leverenz JB, Umar I, Wang Q et al (2007) Proteomic identification of novel proteins in cortical Lewy bodies. Brain Pathol 17:139\u2013145. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00048.x","journal-title":"Brain Pathol"},{"key":"2516_CR7","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1073\/pnas.1913904117","volume":"117","author":"A-L Mahul-Mellier","year":"2020","unstructured":"Mahul-Mellier A-L, Burtscher J, Maharjan N et al (2020) The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc Natl Acad Sci 117:4971\u20134982. https:\/\/doi.org\/10.1073\/pnas.1913904117","journal-title":"Proc Natl Acad Sci"},{"key":"2516_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s004010050001","volume":"100","author":"RJ Castellani","year":"2000","unstructured":"Castellani RJ, Siedlak SL, Perry G, Smith MA (2000) Sequestration of iron by Lewy bodies in Parkinson\u2019s disease. Acta Neuropathol (Berl) 100:111\u2013114. https:\/\/doi.org\/10.1007\/s004010050001","journal-title":"Acta Neuropathol (Berl)"},{"key":"2516_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1056\/NEJM199601113340202","volume":"334","author":"DA Bennett","year":"1996","unstructured":"Bennett DA, Beckett LA, Murray AM et al (1996) Prevalence of Parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 334:71\u201376. https:\/\/doi.org\/10.1056\/NEJM199601113340202","journal-title":"N Engl J Med"},{"key":"2516_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00441-018-2817-y","volume":"373","author":"KJ Billingsley","year":"2018","unstructured":"Billingsley KJ, Bandres-Ciga S, Saez-Atienzar S, Singleton AB (2018) Genetic risk factors in Parkinson\u2019s disease. Cell Tissue Res 373:9\u201320. https:\/\/doi.org\/10.1007\/s00441-018-2817-y","journal-title":"Cell Tissue Res"},{"key":"2516_CR11","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH (1997) Mutation in the -synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047. https:\/\/doi.org\/10.1126\/science.276.5321.2045","journal-title":"Science"},{"key":"2516_CR12","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.neuron.2016.05.040","volume":"90","author":"A Singleton","year":"2016","unstructured":"Singleton A, Hardy J (2016) The evolution of genetics. Neuron 90:1154\u20131163. https:\/\/doi.org\/10.1016\/j.neuron.2016.05.040","journal-title":"Neuron"},{"key":"2516_CR13","doi-asserted-by":"publisher","unstructured":"Ball N, Teo W-P, Chandra S, Chapman J (2019) Parkinson\u2019s disease and the environment. Front Neurol 10:218. https:\/\/doi.org\/10.3389\/fneur.2019.00218","DOI":"10.3389\/fneur.2019.00218"},{"key":"2516_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/art.20761","volume":"52","author":"HK Choi","year":"2005","unstructured":"Choi HK, Liu S, Curhan G (2005) Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: The Third National Health and Nutrition Examination Survey. Arthritis Rheum 52:283\u2013289. https:\/\/doi.org\/10.1002\/art.20761","journal-title":"Arthritis Rheum"},{"key":"2516_CR15","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","volume":"46","author":"JW Langston","year":"1999","unstructured":"Langston JW, Forno LS, Tetrud J et al (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46:598\u2013605. https:\/\/doi.org\/10.1002\/1531-8249(199910)46:4%3c598::AID-ANA7%3e3.0.CO;2-F","journal-title":"Ann Neurol"},{"key":"2516_CR16","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1001\/archneurol.2009.195","volume":"66","author":"CM Tanner","year":"2009","unstructured":"Tanner CM, Ross GW, Jewell SA et al (2009) Occupation and risk of parkinsonism: a multicenter case-control study. Arch Neurol 66:1106\u20131113. https:\/\/doi.org\/10.1001\/archneurol.2009.195","journal-title":"Arch Neurol"},{"key":"2516_CR17","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner CM, Kamel F, Ross GW et al (2011) Rotenone, paraquat, and Parkinson\u2019s disease. Environ Health Perspect 119:866\u2013872. https:\/\/doi.org\/10.1289\/ehp.1002839","journal-title":"Environ Health Perspect"},{"key":"2516_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","volume":"8","author":"SY-Y Pang","year":"2019","unstructured":"Pang SY-Y, Ho PW-L, Liu H-F et al (2019) The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease. Transl Neurodegener 8:23. https:\/\/doi.org\/10.1186\/s40035-019-0165-9","journal-title":"Transl Neurodegener"},{"key":"2516_CR19","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.stemcr.2016.08.012","volume":"7","author":"SY Chung","year":"2016","unstructured":"Chung SY, Kishinevsky S, Mazzulli JR et al (2016) Parkin and PINK1 patient iPSC-derived midbrain dopamine neurons exhibit mitochondrial dysfunction and \u03b1-synuclein accumulation. Stem Cell Rep 7:664\u2013677. https:\/\/doi.org\/10.1016\/j.stemcr.2016.08.012","journal-title":"Stem Cell Rep"},{"key":"2516_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.stem.2011.01.013","volume":"8","author":"HN Nguyen","year":"2011","unstructured":"Nguyen HN, Byers B, Cord B et al (2011) LRRK2 Mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8:267\u2013280. https:\/\/doi.org\/10.1016\/j.stem.2011.01.013","journal-title":"Cell Stem Cell"},{"key":"2516_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","volume":"10","author":"L Puspita","year":"2017","unstructured":"Puspita L, Chung SY, Shim J (2017) Oxidative stress and cellular pathologies in Parkinson\u2019s disease. Mol Brain 10:53. https:\/\/doi.org\/10.1186\/s13041-017-0340-9","journal-title":"Mol Brain"},{"key":"2516_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.307","volume":"5","author":"L Zondler","year":"2014","unstructured":"Zondler L, Miller-Fleming L, Repici M et al (2014) DJ-1 interactions with \u03b1-synuclein attenuate aggregation and cellular toxicity in models of Parkinson\u2019s disease. Cell Death Dis 5:e1350. https:\/\/doi.org\/10.1038\/cddis.2014.307","journal-title":"Cell Death Dis"},{"key":"2516_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/0006-291X(83)91366-9","volume":"111","author":"JR Bucher","year":"1983","unstructured":"Bucher JR, Tien M, Aust SD (1983) The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron. Biochem Biophys Res Commun 111:777\u2013784. https:\/\/doi.org\/10.1016\/0006-291X(83)91366-9","journal-title":"Biochem Biophys Res Commun"},{"key":"2516_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014:360438. https:\/\/doi.org\/10.1155\/2014\/360438","journal-title":"Oxid Med Cell Longev"},{"key":"2516_CR25","doi-asserted-by":"publisher","first-page":"13037","DOI":"10.1021\/ja9029076","volume":"131","author":"L Xu","year":"2009","unstructured":"Xu L, Davis TA, Porter NA (2009) Rate constants for peroxidation of polyunsaturated fatty acids and sterols in solution and in liposomes. J Am Chem Soc 131:13037\u201313044. https:\/\/doi.org\/10.1021\/ja9029076","journal-title":"J Am Chem Soc"},{"key":"2516_CR26","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1351\/pac200779122325","volume":"79","author":"J Prousek","year":"2007","unstructured":"Prousek J (2007) Fenton chemistry in biology and medicine. Pure Appl Chem 79:2325\u20132338. https:\/\/doi.org\/10.1351\/pac200779122325","journal-title":"Pure Appl Chem"},{"key":"2516_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2307\/3579270","volume":"145","author":"P Wardman","year":"1996","unstructured":"Wardman P, Candeias LP (1996) Fenton chemistry: an introduction. Radiat Res 145:523\u2013531. https:\/\/doi.org\/10.2307\/3579270","journal-title":"Radiat Res"},{"key":"2516_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/agm2.12074","volume":"2","author":"Z Zhao","year":"2019","unstructured":"Zhao Z (2019) Iron and oxidizing species in oxidative stress and Alzheimer\u2019s disease. AGING Med 2:82\u201387. https:\/\/doi.org\/10.1002\/agm2.12074","journal-title":"AGING Med"},{"key":"2516_CR29","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1212\/01.wnl.0000286384.31050.b5","volume":"70","author":"WRW Martin","year":"2008","unstructured":"Martin WRW, Wieler M, Gee M (2008) Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70:1411\u20131417. https:\/\/doi.org\/10.1212\/01.wnl.0000286384.31050.b5","journal-title":"Neurology"},{"key":"2516_CR30","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","volume":"330","author":"DT Dexter","year":"1987","unstructured":"Dexter DT, Wells FR, Agid F et al (1987) Increased nigral iron content in postmortem Parkinsonian brain. The Lancet 330:1219\u20131220. https:\/\/doi.org\/10.1016\/S0140-6736(87)91361-4","journal-title":"The Lancet"},{"key":"2516_CR31","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Wells FR, Lee AJ et al (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease. J Neurochem 52:1830\u20131836. https:\/\/doi.org\/10.1111\/j.1471-4159.1989.tb07264.x","journal-title":"J Neurochem"},{"key":"2516_CR32","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1471-4159.1991.tb08170.x","volume":"56","author":"EC Hirsch","year":"1991","unstructured":"Hirsch EC, Brandel J-P, Galle P et al (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson\u2019s disease: an X-ray microanalysis. J Neurochem 56:446\u2013451. https:\/\/doi.org\/10.1111\/j.1471-4159.1991.tb08170.x","journal-title":"J Neurochem"},{"key":"2516_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","volume":"52","author":"P Riederer","year":"1989","unstructured":"Riederer P, Sofic E, Rausch W-D et al (1989) Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J Neurochem 52:515\u2013520. https:\/\/doi.org\/10.1111\/j.1471-4159.1989.tb09150.x","journal-title":"J Neurochem"},{"key":"2516_CR34","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00415-002-0704-6","volume":"249","author":"C Borie","year":"2002","unstructured":"Borie C, Gasparini F, Verpillat P et al (2002) Association study between iron-related genes polymorphisms and Parkinson\u2019s disease. J Neurol 249:801\u2013804. https:\/\/doi.org\/10.1007\/s00415-002-0704-6","journal-title":"J Neurol"},{"key":"2516_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/biof.80","volume":"36","author":"GA Salvador","year":"2010","unstructured":"Salvador GA (2010) Iron in neuronal function and dysfunction. BioFactors 36:103\u2013110. https:\/\/doi.org\/10.1002\/biof.80","journal-title":"BioFactors"},{"key":"2516_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/84859","volume":"27","author":"T LaVaute","year":"2001","unstructured":"LaVaute T, Smith S, Cooperman S et al (2001) Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 27:209\u2013214. https:\/\/doi.org\/10.1038\/84859","journal-title":"Nat Genet"},{"key":"2516_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00702-020-02271-2","volume":"128","author":"A Martin-Bastida","year":"1996","unstructured":"Martin-Bastida A, Tilley BS, Bansal S et al (1996) (2021) Iron and inflammation: in vivo and post-mortem studies in Parkinson\u2019s disease. J Neural Transm Vienna Austria 128:15\u201325. https:\/\/doi.org\/10.1007\/s00702-020-02271-2","journal-title":"J Neural Transm Vienna Austria"},{"key":"2516_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF03033137","volume":"5","author":"M Asanuma","year":"2003","unstructured":"Asanuma M, Miyazaki I, Ogawa N (2003) Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson\u2019s disease. Neurotox Res 5:165\u2013176. https:\/\/doi.org\/10.1007\/BF03033137","journal-title":"Neurotox Res"},{"key":"2516_CR39","first-page":"633","volume":"14","author":"DG Graham","year":"1978","unstructured":"Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14:633\u2013643","journal-title":"Mol Pharmacol"},{"key":"2516_CR40","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/jnc.12686","volume":"129","author":"J Segura-Aguilar","year":"2014","unstructured":"Segura-Aguilar J, Paris I, Mu\u00f1oz P et al (2014) Protective and toxic roles of dopamine in Parkinson\u2019s disease. J Neurochem 129:898\u2013915. https:\/\/doi.org\/10.1111\/jnc.12686","journal-title":"J Neurochem"},{"key":"2516_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1046\/j.1471-4159.1998.70010268.x","volume":"70","author":"E Floor","year":"1998","unstructured":"Floor E, Wetzel MG (1998) Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J Neurochem 70:268\u2013275. https:\/\/doi.org\/10.1046\/j.1471-4159.1998.70010268.x","journal-title":"J Neurochem"},{"key":"2516_CR42","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1046\/j.1471-4159.2001.00186.x","volume":"76","author":"L Zecca","year":"2001","unstructured":"Zecca L, Gallorini M, Sch\u00fcnemann V et al (2001) Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes: nigral iron, neuromelanin and ferritin. J Neurochem 76:1766\u20131773. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00186.x","journal-title":"J Neurochem"},{"key":"2516_CR43","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1073\/pnas.0403495101","volume":"101","author":"L Zecca","year":"2004","unstructured":"Zecca L, Stroppolo A, Gatti A et al (2004) The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci 101:9843\u20139848. https:\/\/doi.org\/10.1073\/pnas.0403495101","journal-title":"Proc Natl Acad Sci"},{"key":"2516_CR44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s11064-011-0619-7","volume":"37","author":"C Venkateshappa","year":"2012","unstructured":"Venkateshappa C, Harish G, Mythri RB et al (2012) Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson\u2019s disease. Neurochem Res 37:358\u2013369. https:\/\/doi.org\/10.1007\/s11064-011-0619-7","journal-title":"Neurochem Res"},{"key":"2516_CR45","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1104\/pp.106.077073","volume":"141","author":"B Halliwell","year":"2006","unstructured":"Halliwell B (2006) Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol 141:312\u2013322. https:\/\/doi.org\/10.1104\/pp.106.077073","journal-title":"Plant Physiol"},{"key":"2516_CR46","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.71547","author":"R Patel","year":"2017","unstructured":"Patel R, Rinker L, Peng J, Chilian WM (2017) Reactive oxygen species: the good and the bad. React Oxyg Species ROS Living Cells. https:\/\/doi.org\/10.5772\/intechopen.71547","journal-title":"React Oxyg Species ROS Living Cells"},{"key":"2516_CR47","first-page":"90","volume":"1","author":"A Agrawal","year":"2010","unstructured":"Agrawal A, Sharma B (2010) Pesticides induced oxidative stress in mammalian systems: a review. Int J Biol Med Res 1:90\u2013104","journal-title":"Int J Biol Med Res"},{"key":"2516_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1191\/0960327102ht212oa","volume":"21","author":"BE Lehnert","year":"2002","unstructured":"Lehnert BE, Iyer R (2002) Exposure to low-level chemicals and ionizing radiation: reactive oxygen species and cellular pathways. Hum Exp Toxicol 21:65\u201369. https:\/\/doi.org\/10.1191\/0960327102ht212oa","journal-title":"Hum Exp Toxicol"},{"key":"2516_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1289\/ehp.99107213","volume":"107","author":"A Sperati","year":"1999","unstructured":"Sperati A, Abeni DD, Tagesson C et al (1999) Exposure to indoor background radiation and urinary concentrations of 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage. Environ Health Perspect 107:3","journal-title":"Environ Health Perspect"},{"key":"2516_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2021.112162","volume":"152","author":"T Wang","year":"2021","unstructured":"Wang T, Ma M, Chen C et al (2021) Three widely used pesticides and their mixtures induced cytotoxicity and apoptosis through the ROS-related caspase pathway in HepG2 cells. Food Chem Toxicol 152:112162. https:\/\/doi.org\/10.1016\/j.fct.2021.112162","journal-title":"Food Chem Toxicol"},{"key":"2516_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj2190001","volume":"219","author":"B Halliwell","year":"1984","unstructured":"Halliwell B, Gutteridge JM (1984) Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219:1\u201314","journal-title":"Biochem J"},{"key":"2516_CR52","doi-asserted-by":"publisher","unstructured":"Han D, Williams E, Cadenas E (2001) Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem J 353(2):411\u2013416. https:\/\/doi.org\/10.1042\/bj3530411","DOI":"10.1042\/bj3530411"},{"key":"2516_CR53","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2012.13659","volume":"142","author":"K Brieger","year":"2012","unstructured":"Brieger K, Schiavone S, Miller FJ, Krause K-H (2012) Reactive oxygen species: from health to disease. Swiss Med Wkly 142:w13659. https:\/\/doi.org\/10.4414\/smw.2012.13659","journal-title":"Swiss Med Wkly"},{"key":"2516_CR54","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/10715760410001712764","volume":"38","author":"SM Schieke","year":"2004","unstructured":"Schieke SM, von Montfort C, Buchczyk DP et al (2004) Singlet oxygen-induced attenuation of growth factor signaling: possible role of ceramides. Free Radic Res 38:729\u2013737. https:\/\/doi.org\/10.1080\/10715760410001712764","journal-title":"Free Radic Res"},{"key":"2516_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1152\/physrev.00018.2001","volume":"82","author":"W Dr\u00f6ge","year":"2002","unstructured":"Dr\u00f6ge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47\u201395. https:\/\/doi.org\/10.1152\/physrev.00018.2001","journal-title":"Physiol Rev"},{"key":"2516_CR56","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1021\/tx200376e","volume":"25","author":"MJ Solivio","year":"2012","unstructured":"Solivio MJ, Nemera DB, Sallans L, Merino EJ (2012) Biologically relevant oxidants cause bound proteins to readily oxidatively crosslink at guanine. Chem Res Toxicol 25:326\u2013336. https:\/\/doi.org\/10.1021\/tx200376e","journal-title":"Chem Res Toxicol"},{"key":"2516_CR57","doi-asserted-by":"publisher","first-page":"11729","DOI":"10.1039\/c4cp00675e","volume":"16","author":"Y Uvaydov","year":"2014","unstructured":"Uvaydov Y, Geacintov NE, Shafirovich V (2014) Generation of guanine\u2013amino acid cross-links by a free radical combination mechanism. Phys Chem Chem Phys PCCP 16:11729\u201311736. https:\/\/doi.org\/10.1039\/c4cp00675e","journal-title":"Phys Chem Chem Phys PCCP"},{"key":"2516_CR58","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2217\/epi.10.43","volume":"2","author":"JB Kwok","year":"2010","unstructured":"Kwok JB (2010) Role of epigenetics in Alzheimer\u2019s and Parkinson\u2019s disease. Epigenomics 2:671\u2013682. https:\/\/doi.org\/10.2217\/epi.10.43","journal-title":"Epigenomics"},{"key":"2516_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.mrfmmm.2011.02.015","volume":"711","author":"D Ziech","year":"2011","unstructured":"Ziech D, Franco R, Pappa A, Panayiotidis MI (2011) Reactive oxygen species (ROS)\u2013\u2013induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res Mol Mech Mutagen 711:167\u2013173. https:\/\/doi.org\/10.1016\/j.mrfmmm.2011.02.015","journal-title":"Mutat Res Mol Mech Mutagen"},{"key":"2516_CR60","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jchromb.2015.12.022","volume":"1019","author":"A Annibal","year":"2016","unstructured":"Annibal A, Colombo G, Milzani A et al (2016) Identification of dityrosine cross-linked sites in oxidized human serum albumin. J Chromatogr B 1019:147\u2013155. https:\/\/doi.org\/10.1016\/j.jchromb.2015.12.022","journal-title":"J Chromatogr B"},{"key":"2516_CR61","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1042\/bj3380629","volume":"338","author":"S Gebicki","year":"1999","unstructured":"Gebicki S, Gebicki JM (1999) Crosslinking of DNA and proteins induced by protein hydroperoxides. Biochem J 338:629\u2013636. https:\/\/doi.org\/10.1042\/bj3380629","journal-title":"Biochem J"},{"key":"2516_CR62","doi-asserted-by":"publisher","unstructured":"Moldogazieva NT, Mokhosoev IM, Feldman NB, Lutsenko SV ROS and RNS signalling: adaptive redox switches through oxidative\/nitrosative protein modifications. Free Radic Res 52(5):507\u2013543. https:\/\/doi.org\/10.1080\/10715762.2018.1457217","DOI":"10.1080\/10715762.2018.1457217"},{"key":"2516_CR63","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00726-003-0011-2","volume":"25","author":"ER Stadtman","year":"2003","unstructured":"Stadtman ER, Levine RL (2003) Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 25:207\u2013218. https:\/\/doi.org\/10.1007\/s00726-003-0011-2","journal-title":"Amino Acids"},{"key":"2516_CR64","doi-asserted-by":"publisher","first-page":"C1440","DOI":"10.1152\/ajpcell.00607.2004","volume":"288","author":"WJH Koopman","year":"2005","unstructured":"Koopman WJH, Verkaart S, Visch H-J et al (2005) Inhibition of complex I of the electron transport chain causes O2\u2212\u00b7-mediated mitochondrial outgrowth. Am J Physiol-Cell Physiol 288:C1440\u2013C1450. https:\/\/doi.org\/10.1152\/ajpcell.00607.2004","journal-title":"Am J Physiol-Cell Physiol"},{"key":"2516_CR65","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s007750050170","volume":"2","author":"P Lipi\u0144ski","year":"1997","unstructured":"Lipi\u0144ski P, Drapier J-C (1997) Interplay between ferritin metabolism, reactive oxygen species and nitric oxide. JBIC J Biol Inorg Chem 2:559\u2013566. https:\/\/doi.org\/10.1007\/s007750050170","journal-title":"JBIC J Biol Inorg Chem"},{"key":"2516_CR66","doi-asserted-by":"publisher","first-page":"48534","DOI":"10.1074\/jbc.M308529200","volume":"278","author":"MP Murphy","year":"2003","unstructured":"Murphy MP, Echtay KS, Blaikie FH et al (2003) Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-targeted spin trap derived from \u03b1-phenyl-N-tert-butylnitrone*. J Biol Chem 278:48534\u201348545. https:\/\/doi.org\/10.1074\/jbc.M308529200","journal-title":"J Biol Chem"},{"key":"2516_CR67","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0302-4598(87)85012-2","volume":"18","author":"RR Crichton","year":"1987","unstructured":"Crichton RR (1987) Iron metabolism and oxygen toxicity. Bioelectrochem Bioenerg 18:105\u2013116. https:\/\/doi.org\/10.1016\/0302-4598(87)85012-2","journal-title":"Bioelectrochem Bioenerg"},{"key":"2516_CR68","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-94-007-5561-1_8","volume":"12","author":"AC Dlouhy","year":"2013","unstructured":"Dlouhy AC, Outten CE (2013) The iron metallome in eukaryotic organisms. Met Ions Life Sci 12:241\u2013278. https:\/\/doi.org\/10.1007\/978-94-007-5561-1_8","journal-title":"Met Ions Life Sci"},{"key":"2516_CR69","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","volume":"155","author":"FA Zucca","year":"2017","unstructured":"Zucca FA, Segura-Aguilar J, Ferrari E et al (2017) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson\u2019s disease. Prog Neurobiol 155:96\u2013119. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.09.012","journal-title":"Prog Neurobiol"},{"key":"2516_CR70","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1006\/jmbi.1993.1592","volume":"234","author":"M Gerstein","year":"1993","unstructured":"Gerstein M, Anderson BF, Norris GE et al (1993) Domain closure in lactoferrin: two hinges produce a see-saw motion between alternative close-packed interfaces. J Mol Biol 234:357\u2013372. https:\/\/doi.org\/10.1006\/jmbi.1993.1592","journal-title":"J Mol Biol"},{"key":"2516_CR71","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1089\/ars.2007.1893","volume":"10","author":"EL Mackenzie","year":"2008","unstructured":"Mackenzie EL, Iwasaki K, Tsuji Y (2008) Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal 10:997\u20131030. https:\/\/doi.org\/10.1089\/ars.2007.1893","journal-title":"Antioxid Redox Signal"},{"key":"2516_CR72","doi-asserted-by":"publisher","first-page":"311","DOI":"10.11613\/BM.2012.034","volume":"22","author":"L Tandara","year":"2012","unstructured":"Tandara L, Salamunic I (2012) Iron metabolism: current facts and future directions. Biochem Medica 22:311\u2013328","journal-title":"Biochem Medica"},{"key":"2516_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4684-0943-7","volume-title":"Protein-Metal Interactions","author":"E Frieden","year":"1974","unstructured":"Frieden E (1974) The Evolution of Metals as Essential Elements [with special reference to iron and copper]. In: Friedman M (ed) Protein-Metal Interactions. Springer, New York, Boston, MA, pp 1\u201331"},{"key":"2516_CR74","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1242\/dmm.009019","volume":"5","author":"TA Rouault","year":"2012","unstructured":"Rouault TA (2012) Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease. Dis Model Mech 5:155\u2013164. https:\/\/doi.org\/10.1242\/dmm.009019","journal-title":"Dis Model Mech"},{"key":"2516_CR75","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/iub.1150","volume":"65","author":"MI Flydal","year":"2013","unstructured":"Flydal MI, Martinez A (2013) Phenylalanine hydroxylase: function, structure, and regulation. IUBMB Life 65:341\u2013349. https:\/\/doi.org\/10.1002\/iub.1150","journal-title":"IUBMB Life"},{"key":"2516_CR76","doi-asserted-by":"publisher","first-page":"12087","DOI":"10.1021\/bi8015263","volume":"47","author":"MS Windahl","year":"2008","unstructured":"Windahl MS, Petersen CR, Christensen HEM, Harris P (2008) Crystal structure of tryptophan hydroxylase with bound amino acid substrate. Biochemistry 47:12087\u201312094. https:\/\/doi.org\/10.1021\/bi8015263","journal-title":"Biochemistry"},{"key":"2516_CR77","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1021\/tx0497144","volume":"18","author":"I Paris","year":"2005","unstructured":"Paris I, Martinez-Alvarado P, C\u00e1rdenas S et al (2005) Dopamine-dependent iron toxicity in cells derived from rat hypothalamus. Chem Res Toxicol 18:415\u2013419. https:\/\/doi.org\/10.1021\/tx0497144","journal-title":"Chem Res Toxicol"},{"key":"2516_CR78","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/j.1471-4159.2004.02931.x","volume":"92","author":"I Paris","year":"2005","unstructured":"Paris I, Martinez-Alvarado P, Perez-Pastene C et al (2005) Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra. J Neurochem 92:1021\u20131032. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02931.x","journal-title":"J Neurochem"},{"key":"2516_CR79","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7","volume":"17","author":"JR Connor","year":"1996","unstructured":"Connor JR, Menzies SL (1996) Relationship of iron to oligondendrocytes and myelination. Glia 17:83\u201393. https:\/\/doi.org\/10.1002\/(SICI)1098-1136(199606)17:2%3c83::AID-GLIA1%3e3.0.CO;2-7","journal-title":"Glia"},{"key":"2516_CR80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jtemb.2013.08.001","volume":"28","author":"P Ramos","year":"2014","unstructured":"Ramos P, Santos A, Pinto NR et al (2014) Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes. J Trace Elem Med Biol 28:13\u201317. https:\/\/doi.org\/10.1016\/j.jtemb.2013.08.001","journal-title":"J Trace Elem Med Biol"},{"key":"2516_CR81","doi-asserted-by":"publisher","first-page":"17982","DOI":"10.1523\/JNEUROSCI.2250-11.2011","volume":"31","author":"G Rathnasamy","year":"2011","unstructured":"Rathnasamy G, Ling E-A, Kaur C (2011) Iron and iron regulatory proteins in amoeboid microglial cells are linked to oligodendrocyte death in hypoxic neonatal rat periventricular white matter through production of proinflammatory cytokines and reactive oxygen\/nitrogen species. J Neurosci 31:17982\u201317995. https:\/\/doi.org\/10.1523\/JNEUROSCI.2250-11.2011","journal-title":"J Neurosci"},{"key":"2516_CR82","doi-asserted-by":"publisher","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4(1):1\u20139. https:\/\/doi.org\/10.1186\/s40035-015-0042-0","DOI":"10.1186\/s40035-015-0042-0"},{"key":"2516_CR83","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0014-5793(01)03269-0","volume":"510","author":"L Zecca","year":"2002","unstructured":"Zecca L, Fariello R, Riederer P et al (2002) The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson\u2019s disease. FEBS Lett 510:216\u2013220. https:\/\/doi.org\/10.1016\/S0014-5793(01)03269-0","journal-title":"FEBS Lett"},{"key":"2516_CR84","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1042\/BST20130130","volume":"41","author":"DR Brown","year":"2013","unstructured":"Brown DR (2013) \u03b1-Synuclein as a ferrireductase. Biochem Soc Trans 41:1513\u20131517. https:\/\/doi.org\/10.1042\/BST20130130","journal-title":"Biochem Soc Trans"},{"key":"2516_CR85","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00702-020-02192-0","volume":"127","author":"J Sian-Hulsmann","year":"2020","unstructured":"Sian-Hulsmann J, Riederer P (2020) The role of alpha-synuclein as ferrireductase in neurodegeneration associated with Parkinson\u2019s disease. J Neural Transm 127:749\u2013754. https:\/\/doi.org\/10.1007\/s00702-020-02192-0","journal-title":"J Neural Transm"},{"key":"2516_CR86","doi-asserted-by":"publisher","unstructured":"Emamzadeh FN (2016) Alpha-synuclein structure, functions, and interactions. J Res Med Sci Off J Isfahan Univ Med Sci 21. https:\/\/doi.org\/10.4103\/1735-1995.181989","DOI":"10.4103\/1735-1995.181989"},{"key":"2516_CR87","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1074\/jbc.M107045200","volume":"277","author":"H-J Lee","year":"2002","unstructured":"Lee H-J, Choi C, Lee S-J (2002) Membrane-bound \u03b1-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form*. J Biol Chem 277:671\u2013678. https:\/\/doi.org\/10.1074\/jbc.M107045200","journal-title":"J Biol Chem"},{"key":"2516_CR88","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"H-J Lee","year":"2005","unstructured":"Lee H-J, Patel S, Lee S-J (2005) Intravesicular localization and exocytosis of \u03b1-synuclein and its aggregates. J Neurosci 25:6016\u20136024","journal-title":"J Neurosci"},{"key":"2516_CR89","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1097\/WNR.0b013e3282f03db4","volume":"18","author":"W-W Li","year":"2007","unstructured":"Li W-W, Yang R, Guo J-C et al (2007) Localization of \u03b1-synuclein to mitochondria within midbrain of mice. NeuroReport 18:1543\u20131546. https:\/\/doi.org\/10.1097\/WNR.0b013e3282f03db4","journal-title":"NeuroReport"},{"key":"2516_CR90","doi-asserted-by":"publisher","unstructured":"Stefanis L (2012) \u03b1-Synuclein in Parkinson\u2019s Disease. Cold Spring Harb Perspect Med 2:2(2):a009399. https:\/\/doi.org\/10.1101\/cshperspect.a009399","DOI":"10.1101\/cshperspect.a009399"},{"key":"2516_CR91","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JPD-150642","volume":"5","author":"J Burr\u00e9","year":"2015","unstructured":"Burr\u00e9 J (2015) The synaptic function of \u03b1-synuclein. J Park Dis 5:699\u2013713. https:\/\/doi.org\/10.3233\/JPD-150642","journal-title":"J Park Dis"},{"key":"2516_CR92","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","volume":"80","author":"C Proukakis","year":"2013","unstructured":"Proukakis C, Dudzik CG, Brier T et al (2013) A novel \u03b1-synuclein missense mutation in Parkinson disease. Neurology 80:1062\u20131064. https:\/\/doi.org\/10.1212\/WNL.0b013e31828727ba","journal-title":"Neurology"},{"key":"2516_CR93","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.neurobiolaging.2014.10.042","volume":"36","author":"W Xu","year":"2015","unstructured":"Xu W, Tan L, Yu J-T (2015) The link between the SNCA gene and parkinsonism. Neurobiol Aging 36:1505\u20131518. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.10.042","journal-title":"Neurobiol Aging"},{"key":"2516_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015814","volume":"6","author":"P Davies","year":"2011","unstructured":"Davies P, Moualla D, Brown DR (2011) Alpha-synuclein is a cellular ferrireductase. PLoS ONE 6:e15814. https:\/\/doi.org\/10.1371\/journal.pone.0015814","journal-title":"PLoS ONE"},{"key":"2516_CR95","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1042\/BJ20111451","volume":"441","author":"J Lee","year":"2012","unstructured":"Lee J, Giordano S, Zhang J (2012) Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J 441:523\u2013540. https:\/\/doi.org\/10.1042\/BJ20111451","journal-title":"Biochem J"},{"key":"2516_CR96","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.tcb.2011.03.007","volume":"21","author":"JM Gump","year":"2011","unstructured":"Gump JM, Thorburn A (2011) Autophagy and apoptosis \u2014 what\u2019s the connection? Trends Cell Biol 21:387\u2013392. https:\/\/doi.org\/10.1016\/j.tcb.2011.03.007","journal-title":"Trends Cell Biol"},{"key":"2516_CR97","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s12035-014-8921-4","volume":"52","author":"Z Hu","year":"2015","unstructured":"Hu Z, Yang B, Mo X, Xiao H (2015) Mechanism and regulation of autophagy and its role in neuronal diseases. Mol Neurobiol 52:1190\u20131209. https:\/\/doi.org\/10.1007\/s12035-014-8921-4","journal-title":"Mol Neurobiol"},{"key":"2516_CR98","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/mds.26477","volume":"31","author":"M Xilouri","year":"2016","unstructured":"Xilouri M, Brekk OR, Stefanis L (2016) Autophagy and alpha-synuclein: relevance to Parkinson\u2019s Disease and related synucleopathies. Mov Disord 31:178\u2013192. https:\/\/doi.org\/10.1002\/mds.26477","journal-title":"Mov Disord"},{"key":"2516_CR99","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/cr.2011.152","volume":"22","author":"E Wirawan","year":"2012","unstructured":"Wirawan E, Berghe TV, Lippens S et al (2012) Autophagy: for better or for worse. Cell Res 22:43\u201361. https:\/\/doi.org\/10.1038\/cr.2011.152","journal-title":"Cell Res"},{"key":"2516_CR100","doi-asserted-by":"publisher","first-page":"8136","DOI":"10.1007\/s12035-019-01654-1","volume":"56","author":"MJ Ramirez-Moreno","year":"2019","unstructured":"Ramirez-Moreno MJ, Duarte-Jurado AP, Gopar-Cuevas Y et al (2019) Autophagy stimulation decreases dopaminergic neuronal death mediated by oxidative stress. Mol Neurobiol 56:8136\u20138156. https:\/\/doi.org\/10.1007\/s12035-019-01654-1","journal-title":"Mol Neurobiol"},{"key":"2516_CR101","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/jnen\/60.10.937","volume":"60","author":"AU Zaidi","year":"2001","unstructured":"Zaidi AU, McDonough JS, Klocke BJ et al (2001) Chloroquine-induced neuronal cell death is p53 and Bcl-2 family-dependent but caspase-independent. J Neuropathol Exp Neurol 60:937\u2013945. https:\/\/doi.org\/10.1093\/jnen\/60.10.937","journal-title":"J Neuropathol Exp Neurol"},{"key":"2516_CR102","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1172\/JCI32806","volume":"118","author":"M Martinez-Vicente","year":"2008","unstructured":"Martinez-Vicente M, Talloczy Z, Kaushik S et al (2008) Dopamine-modified \u03b1-synuclein blocks chaperone-mediated autophagy. J Clin Invest 118:777\u2013788. https:\/\/doi.org\/10.1172\/JCI32806","journal-title":"J Clin Invest"},{"key":"2516_CR103","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1073\/pnas.0507436103","volume":"103","author":"AC Massey","year":"2006","unstructured":"Massey AC, Kaushik S, Sovak G et al (2006) Consequences of the selective blockage of chaperone-mediated autophagy. Proc Natl Acad Sci U S A 103:5805\u20135810. https:\/\/doi.org\/10.1073\/pnas.0507436103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2516_CR104","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nn.3350","volume":"16","author":"SJ Orenstein","year":"2013","unstructured":"Orenstein SJ, Kuo S-H, Tasset I et al (2013) Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci 16:394\u2013406. https:\/\/doi.org\/10.1038\/nn.3350","journal-title":"Nat Neurosci"},{"key":"2516_CR105","doi-asserted-by":"publisher","first-page":"23542","DOI":"10.1074\/jbc.M801992200","volume":"283","author":"T Vogiatzi","year":"2008","unstructured":"Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L (2008) Wild type \u03b1-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 283:23542\u201323556. https:\/\/doi.org\/10.1074\/jbc.M801992200","journal-title":"J Biol Chem"},{"key":"2516_CR106","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM (2004) Impaired degradation of mutant -synuclein by chaperone-mediated autophagy. Science 305:1292\u20131295. https:\/\/doi.org\/10.1126\/science.1101738","journal-title":"Science"},{"key":"2516_CR107","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/toxsci\/kfq170","volume":"117","author":"R Castino","year":"2010","unstructured":"Castino R, Bellio N, Follo C et al (2010) Inhibition of PI3k class III\u2013dependent autophagy prevents apoptosis and necrosis by oxidative stress in dopaminergic neuroblastoma cells. Toxicol Sci 117:152\u2013162. https:\/\/doi.org\/10.1093\/toxsci\/kfq170","journal-title":"Toxicol Sci"},{"key":"2516_CR108","doi-asserted-by":"publisher","first-page":"33380","DOI":"10.1074\/jbc.m111.268409","volume":"286","author":"KCM Chew","year":"2011","unstructured":"Chew KCM, Ang E-T, Tai YK et al (2011) Enhanced autophagy from chronic toxicity of iron and mutant A53T \u03b1-synuclein: implications for neuronal cell death in Parkinson disease. J Biol Chem 286:33380\u201333389. https:\/\/doi.org\/10.1074\/jbc.m111.268409","journal-title":"J Biol Chem"},{"key":"2516_CR109","doi-asserted-by":"publisher","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","volume":"31","author":"D Ebrahimi-Fakhari","year":"2011","unstructured":"Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z et al (2011) Distinct roles in vivo for the ubiquitin\u2013proteasome system and the autophagy\u2013lysosomal pathway in the degradation of \u03b1-synuclein. J Neurosci 31:14508\u201314520","journal-title":"J Neurosci"},{"key":"2516_CR110","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.toxlet.2017.08.006","volume":"280","author":"X He","year":"2017","unstructured":"He X, Yuan W, Li Z, Feng J (2017) An autophagic mechanism is involved in the 6-hydroxydopamine-induced neurotoxicity in vivo. Toxicol Lett 280:29\u201340. https:\/\/doi.org\/10.1016\/j.toxlet.2017.08.006","journal-title":"Toxicol Lett"},{"key":"2516_CR111","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/jnen\/nly024","volume":"77","author":"O Scudamore","year":"2018","unstructured":"Scudamore O, Ciossek T (2018) Increased oxidative stress exacerbates \u03b1-synuclein aggregation in vivo. J Neuropathol Exp Neurol 77:443\u2013453. https:\/\/doi.org\/10.1093\/jnen\/nly024","journal-title":"J Neuropathol Exp Neurol"},{"key":"2516_CR112","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mcn.2014.08.002","volume":"62","author":"R Perfeito","year":"2014","unstructured":"Perfeito R, L\u00e1zaro DF, Outeiro TF, Rego AC (2014) Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells. Mol Cell Neurosci 62:51\u201359. https:\/\/doi.org\/10.1016\/j.mcn.2014.08.002","journal-title":"Mol Cell Neurosci"},{"key":"2516_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062277","volume":"8","author":"A Bender","year":"2013","unstructured":"Bender A, Desplats P, Spencer B et al (2013) TOM40 mediates mitochondrial dysfunction induced by \u03b1-synuclein accumulation in Parkinson\u2019s disease. PLoS ONE 8:e62277. https:\/\/doi.org\/10.1371\/journal.pone.0062277","journal-title":"PLoS ONE"},{"key":"2516_CR114","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell 18:e13031. https:\/\/doi.org\/10.1111\/acel.13031","journal-title":"Aging Cell"},{"key":"2516_CR115","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1089\/ars.2015.6343","volume":"24","author":"E Deas","year":"2015","unstructured":"Deas E, Cremades N, Angelova PR et al (2015) Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson\u2019s disease. Antioxid Redox Signal 24:376\u2013391. https:\/\/doi.org\/10.1089\/ars.2015.6343","journal-title":"Antioxid Redox Signal"},{"key":"2516_CR116","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla LF, Song P, Mazzulli JR et al (2017) Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science 357:1255\u20131261. https:\/\/doi.org\/10.1126\/science.aam9080","journal-title":"Science"},{"key":"2516_CR117","doi-asserted-by":"crossref","unstructured":"Abeyawardhane DL, Lucas HR (2019) Iron redox chemistry and implications in the Parkinson\u2019s disease brain. Oxid Med Cell Longev. https:\/\/www.hindawi.com\/journals\/omcl\/2019\/4609702\/","DOI":"10.1155\/2019\/4609702"},{"key":"2516_CR118","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00401-007-0303-9","volume":"115","author":"WJ Burke","year":"2008","unstructured":"Burke WJ, Kumar VB, Pandey N et al (2008) Aggregation of \u03b1-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine. Acta Neuropathol (Berl) 115:193\u2013203. https:\/\/doi.org\/10.1007\/s00401-007-0303-9","journal-title":"Acta Neuropathol (Berl)"},{"key":"2516_CR119","doi-asserted-by":"publisher","first-page":"27660","DOI":"10.1074\/jbc.M115.686584","volume":"290","author":"C Follmer","year":"2015","unstructured":"Follmer C, Coelho-Cerqueira E, Yatabe-Franco DY et al (2015) Oligomerization and membrane-binding properties of covalent adducts formed by the interaction of \u03b1-synuclein with the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL). J Biol Chem 290:27660\u201327679. https:\/\/doi.org\/10.1074\/jbc.M115.686584","journal-title":"J Biol Chem"},{"key":"2516_CR120","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0006-8993(03)03354-7","volume":"989","author":"WJ Burke","year":"2003","unstructured":"Burke WJ, Li SW, Williams EA et al (2003) 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson\u2019s disease pathogenesis. Brain Res 989:205\u2013213. https:\/\/doi.org\/10.1016\/S0006-8993(03)03354-7","journal-title":"Brain Res"},{"key":"2516_CR121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015251","volume":"5","author":"WM Panneton","year":"2010","unstructured":"Panneton WM, Kumar VB, Gan Q et al (2010) The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis. PLoS ONE 5:e15251. https:\/\/doi.org\/10.1371\/journal.pone.0015251","journal-title":"PLoS ONE"},{"key":"2516_CR122","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bbrc.2010.03.044","volume":"394","author":"M Bisaglia","year":"2010","unstructured":"Bisaglia M, Tosatto L, Munari F et al (2010) Dopamine quinones interact with \u03b1-synuclein to form unstructured adducts. Biochem Biophys Res Commun 394:424\u2013428. https:\/\/doi.org\/10.1016\/j.bbrc.2010.03.044","journal-title":"Biochem Biophys Res Commun"},{"key":"2516_CR123","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/toxsci\/kfv016","volume":"145","author":"P Mu\u00f1oz","year":"2015","unstructured":"Mu\u00f1oz P, Cardenas S, Huenchuguala S et al (2015) DT-diaphorase prevents aminochrome-induced alpha-synuclein oligomer formation and neurotoxicity. Toxicol Sci 145:37\u201347. https:\/\/doi.org\/10.1093\/toxsci\/kfv016","journal-title":"Toxicol Sci"},{"key":"2516_CR124","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s12640-017-9747-4","volume":"32","author":"PS Mu\u00f1oz","year":"2017","unstructured":"Mu\u00f1oz PS, Segura-Aguilar J (2017) DT-diaphorase protects against autophagy induced by aminochrome-dependent alpha-synuclein oligomers. Neurotox Res 32:362\u2013367. https:\/\/doi.org\/10.1007\/s12640-017-9747-4","journal-title":"Neurotox Res"},{"key":"2516_CR125","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mds.25373","volume":"28","author":"CW Olanow","year":"2013","unstructured":"Olanow CW, Brundin P (2013) Parkinson\u2019s disease and alpha synuclein: is Parkinson\u2019s disease a prion-like disorder? Mov Disord 28:31\u201340. https:\/\/doi.org\/10.1002\/mds.25373","journal-title":"Mov Disord"},{"key":"2516_CR126","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3174\/ajnr.A5702","volume":"39","author":"N Pyatigorskaya","year":"2018","unstructured":"Pyatigorskaya N, Magnin B, Mongin M et al (2018) Comparative study of MRI biomarkers in the substantia nigra to discriminate idiopathic Parkinson disease. Am J Neuroradiol 39:1460\u20131467. https:\/\/doi.org\/10.3174\/ajnr.A5702","journal-title":"Am J Neuroradiol"},{"key":"2516_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-018-0047-3","volume":"4","author":"D Sulzer","year":"2018","unstructured":"Sulzer D, Cassidy C, Horga G et al (2018) Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson\u2019s disease. Npj Park Dis 4:1\u201313. https:\/\/doi.org\/10.1038\/s41531-018-0047-3","journal-title":"Npj Park Dis"},{"key":"2516_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-018-0050-8","volume":"4","author":"FA Zucca","year":"2018","unstructured":"Zucca FA, Vanna R, Cupaioli FA et al (2018) Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson\u2019s disease. Npj Park Dis 4:1\u201323. https:\/\/doi.org\/10.1038\/s41531-018-0050-8","journal-title":"Npj Park Dis"},{"key":"2516_CR129","doi-asserted-by":"publisher","unstructured":"Minakaki G, Krainc D, Burbulla LF (2020) The convergence of alpha-synuclein, mitochondrial, and lysosomal pathways in vulnerability of midbrain dopaminergic neurons in Parkinson\u2019s disease. Front Cell Dev Biol 8. https:\/\/doi.org\/10.3389\/fcell.2020.580634","DOI":"10.3389\/fcell.2020.580634"},{"key":"2516_CR130","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/s0304-3940(98)00649-1","volume":"253","author":"K Ikemoto","year":"1998","unstructured":"Ikemoto K, Nagatsu I, Ito S et al (1998) Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra? Neurosci Lett 253:198\u2013200. https:\/\/doi.org\/10.1016\/s0304-3940(98)00649-1","journal-title":"Neurosci Lett"},{"key":"2516_CR131","doi-asserted-by":"publisher","unstructured":"Tribl F, Arzberger T, Riederer P, Gerlach M (2007) Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis. J Neural Transm Suppl 51\u201355. https:\/\/doi.org\/10.1007\/978-3-211-73574-9_8","DOI":"10.1007\/978-3-211-73574-9_8"},{"key":"2516_CR132","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/0003-9861(84)90217-0","volume":"235","author":"M Jimenez","year":"1984","unstructured":"Jimenez M, Garcia-Carmona F, Garcia-Canovas F et al (1984) Chemical intermediates in dopamine oxidation by tyrosinase, and kinetic studies of the process. Arch Biochem Biophys 235:438\u2013448. https:\/\/doi.org\/10.1016\/0003-9861(84)90217-0","journal-title":"Arch Biochem Biophys"},{"key":"2516_CR133","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41467-019-08858-y","volume":"10","author":"I Carballo-Carbajal","year":"2019","unstructured":"Carballo-Carbajal I, Laguna A, Romero-Gim\u00e9nez J et al (2019) Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson\u2019s disease pathogenesis. Nat Commun 10:973. https:\/\/doi.org\/10.1038\/s41467-019-08858-y","journal-title":"Nat Commun"},{"key":"2516_CR134","doi-asserted-by":"publisher","unstructured":"Sun Y, Pham AN, Hare DJ, Waite TD (2018) Kinetic modeling of pH-dependent oxidation of dopamine by iron and its relevance to Parkinson\u2019s disease. Front Neurosci 12:859. https:\/\/doi.org\/10.3389\/fnins.2018.00859","DOI":"10.3389\/fnins.2018.00859"},{"key":"2516_CR135","doi-asserted-by":"publisher","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","volume":"97","author":"D Sulzer","year":"2000","unstructured":"Sulzer D, Bogulavsky J, Larsen KE et al (2000) Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci 97:11869\u201311874. https:\/\/doi.org\/10.1073\/pnas.97.22.11869","journal-title":"Proc Natl Acad Sci"},{"key":"2516_CR136","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/cne.20098","volume":"473","author":"C-L Liang","year":"2004","unstructured":"Liang C-L, Nelson O, Yazdani U et al (2004) Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons. J Comp Neurol 473:97\u2013106. https:\/\/doi.org\/10.1002\/cne.20098","journal-title":"J Comp Neurol"},{"key":"2516_CR137","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048490","volume":"7","author":"M Engelen","year":"2012","unstructured":"Engelen M, Vanna R, Bellei C et al (2012) Neuromelanins of human brain have soluble and insoluble components with dolichols attached to the melanic structure. PLoS ONE 7:e48490. https:\/\/doi.org\/10.1371\/journal.pone.0048490","journal-title":"PLoS ONE"},{"key":"2516_CR138","doi-asserted-by":"publisher","first-page":"17567","DOI":"10.1073\/pnas.0808768105","volume":"105","author":"L Zecca","year":"2008","unstructured":"Zecca L, Bellei C, Costi P et al (2008) New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals. Proc Natl Acad Sci 105:17567\u201317572","journal-title":"Proc Natl Acad Sci"},{"key":"2516_CR139","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12640-013-9435-y","volume":"25","author":"FA Zucca","year":"2014","unstructured":"Zucca FA, Basso E, Cupaioli FA et al (2014) Neuromelanin of the human substantia nigra: an update. Neurotox Res 25:13\u201323. https:\/\/doi.org\/10.1007\/s12640-013-9435-y","journal-title":"Neurotox Res"},{"key":"2516_CR140","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/jnc.13648","volume":"138","author":"A Biesemeier","year":"2016","unstructured":"Biesemeier A, Eibl O, Eswara S et al (2016) Elemental mapping of neuromelanin organelles of human substantia nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry. J Neurochem 138:339\u2013353. https:\/\/doi.org\/10.1111\/jnc.13648","journal-title":"J Neurochem"},{"key":"2516_CR141","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E Hirsch","year":"1988","unstructured":"Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature 334:345\u2013348. https:\/\/doi.org\/10.1038\/334345a0","journal-title":"Nature"},{"key":"2516_CR142","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38:1285\u20131285. https:\/\/doi.org\/10.1212\/WNL.38.8.1285","journal-title":"Neurology"},{"key":"2516_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.02-0314fje","volume":"17","author":"H Wilms","year":"2003","unstructured":"Wilms H, Rosenstiel P, Sievers J et al (2003) Activation of microglia by human neuromelanin is NF-\u03baB-dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson\u2019s disease. FASEB J 17:1\u201320. https:\/\/doi.org\/10.1096\/fj.02-0314fje","journal-title":"FASEB J"},{"key":"2516_CR144","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12640-009-9140-z","volume":"19","author":"W Zhang","year":"2011","unstructured":"Zhang W, Phillips K, Wielgus AR et al (2011) Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson\u2019s disease. Neurotox Res 19:63\u201372. https:\/\/doi.org\/10.1007\/s12640-009-9140-z","journal-title":"Neurotox Res"},{"key":"2516_CR145","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00401-007-0250-5","volume":"114","author":"TG Beach","year":"2007","unstructured":"Beach TG, Sue LI, Walker DG et al (2007) Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits. Acta Neuropathol (Berl) 114:419\u2013424. https:\/\/doi.org\/10.1007\/s00401-007-0250-5","journal-title":"Acta Neuropathol (Berl)"},{"key":"2516_CR146","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1021\/jm970099t","volume":"40","author":"A Pezzella","year":"1997","unstructured":"Pezzella A, d\u2019Ischia M, Napolitano A et al (1997) Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinson\u2019s disease. J Med Chem 40:2211\u20132216. https:\/\/doi.org\/10.1021\/jm970099t","journal-title":"J Med Chem"},{"key":"2516_CR147","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0162-0134(99)00238-X","volume":"79","author":"W Linert","year":"2000","unstructured":"Linert W, Jameson GNL (2000) Redox reactions of neurotransmitters possibly involved in the progression of Parkinson\u2019s Disease. J Inorg Biochem 79:319\u2013326. https:\/\/doi.org\/10.1016\/S0162-0134(99)00238-X","journal-title":"J Inorg Biochem"},{"key":"2516_CR148","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.2166\/wst.2011.420","volume":"64","author":"D Contreras","year":"2011","unstructured":"Contreras D, Rodr\u00edguez J, Basaez L et al (2011) New insights in the dihydroxybenzenes-driven Fenton reaction: electrochemical study of interaction between dihydroxybenzenes and Fe(III). Water Sci Technol 64:2103\u20132108. https:\/\/doi.org\/10.2166\/wst.2011.420","journal-title":"Water Sci Technol"},{"key":"2516_CR149","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.gca.2005.11.020","volume":"70","author":"M Uchimiya","year":"2006","unstructured":"Uchimiya M, Stone AT (2006) Redox reactions between iron and quinones: thermodynamic constraints. Geochim Cosmochim Acta 70:1388\u20131401. https:\/\/doi.org\/10.1016\/j.gca.2005.11.020","journal-title":"Geochim Cosmochim Acta"},{"key":"2516_CR150","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1002\/anie.201811122","volume":"58","author":"E Monzani","year":"2019","unstructured":"Monzani E, Nicolis S, Dell\u2019Acqua S et al (2019) Dopamine, oxidative stress and protein\u2013quinone modifications in Parkinson\u2019s and other neurodegenerative diseases. Angew Chem Int Ed 58:6512\u20136527. https:\/\/doi.org\/10.1002\/anie.201811122","journal-title":"Angew Chem Int Ed"},{"key":"2516_CR151","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tins.2003.08.009","volume":"26","author":"L Zecca","year":"2003","unstructured":"Zecca L, Zucca FA, Wilms H, Sulzer D (2003) Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends Neurosci 26:578\u2013580. https:\/\/doi.org\/10.1016\/j.tins.2003.08.009","journal-title":"Trends Neurosci"},{"key":"2516_CR152","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.freeradbiomed.2010.09.010","volume":"49","author":"ZD Zhou","year":"2010","unstructured":"Zhou ZD, Lan YH, Tan EK, Lim TM (2010) Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: Implications for iron-related dopaminergic neuron degeneration. Free Radic Biol Med 49:1856\u20131871. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.09.010","journal-title":"Free Radic Biol Med"},{"key":"2516_CR153","first-page":"1","volume":"5","author":"W Zhang","year":"2013","unstructured":"Zhang W, Zecca L, Wilson B et al (2013) Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death. Front Biosci Elite Ed 5:1\u201311","journal-title":"Front Biosci Elite Ed"},{"key":"2516_CR154","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/2210290601102010028","volume":"5","author":"S Li","year":"2011","unstructured":"Li S (2011) Chemical composition and product quality control of turmeric (Curcuma longa L.). Pharm Crops 5:28\u201354. https:\/\/doi.org\/10.2174\/2210290601102010028","journal-title":"Pharm Crops"},{"key":"2516_CR155","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cbpc.2018.09.002","volume":"215","author":"J Akter","year":"2019","unstructured":"Akter J, Hossain MdA, Takara K et al (2019) Antioxidant activity of different species and varieties of turmeric (Curcuma spp): Isolation of active compounds. Comp Biochem Physiol Part C Toxicol Pharmacol 215:9\u201317. https:\/\/doi.org\/10.1016\/j.cbpc.2018.09.002","journal-title":"Comp Biochem Physiol Part C Toxicol Pharmacol"},{"key":"2516_CR156","doi-asserted-by":"publisher","unstructured":"Kasai H, Yamane Y, Ikegami-Kawai M, Sudo H (2019) Analysis of compounds of curcuma rhizome using mass spectrometry and investigation of the antioxidant activity of rhizome extracts. Med Aromat Plants 8. https:\/\/doi.org\/10.35248\/2167-0412.19.8.336","DOI":"10.35248\/2167-0412.19.8.336"},{"key":"2516_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2019.02.020","volume":"406","author":"S Abrahams","year":"2019","unstructured":"Abrahams S, Haylett WL, Johnson G et al (2019) Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: a review. Neuroscience 406:1\u201321. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.02.020","journal-title":"Neuroscience"},{"key":"2516_CR158","doi-asserted-by":"publisher","first-page":"550","DOI":"10.2174\/138955710791384081","volume":"10","author":"S Gao","year":"2010","unstructured":"Gao S, Hu M (2010) Bioavailability challenges associated with development of anti-cancer phenolics. Mini Rev Med Chem 10:550\u2013567","journal-title":"Mini Rev Med Chem"},{"key":"2516_CR159","unstructured":"Hussain MB, Hassan S, Waheed M et al (2019) Bioavailability and metabolic pathway of phenolic compounds. In: Plant Physiological Aspects of Phenolic Compounds. IntechOpen"},{"key":"2516_CR160","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/BPL-200099","volume":"6","author":"R Carecho","year":"2020","unstructured":"Carecho R, Carregosa D, dos Santos CN (2020) Low molecular weight (poly)phenol metabolites across the blood-brain barrier: the underexplored journey. Brain Plast 6:193\u2013214. https:\/\/doi.org\/10.3233\/BPL-200099","journal-title":"Brain Plast"},{"key":"2516_CR161","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3390\/nu12051531","volume":"12","author":"I Grabska-Kobylecka","year":"2020","unstructured":"Grabska-Kobylecka I, Kaczmarek-Bak J, Figlus M et al (2020) The presence of caffeic acid in cerebrospinal fluid: evidence that dietary polyphenols can cross the blood-brain barrier in humans. Nutrients 12:1531. https:\/\/doi.org\/10.3390\/nu12051531","journal-title":"Nutrients"},{"key":"2516_CR162","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijpharm.2011.06.030","volume":"416","author":"Y-M Tsai","year":"2011","unstructured":"Tsai Y-M, Chien C-F, Lin L-C, Tsai T-H (2011) Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm 416:331\u2013338. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.06.030","journal-title":"Int J Pharm"},{"key":"2516_CR163","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00204-017-1939-4","volume":"91","author":"F Ullah","year":"2017","unstructured":"Ullah F, Liang A, Rangel A et al (2017) High bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation. Arch Toxicol 91:1623\u20131634. https:\/\/doi.org\/10.1007\/s00204-017-1939-4","journal-title":"Arch Toxicol"},{"key":"2516_CR164","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1172\/JCI119832","volume":"100","author":"DB Agus","year":"1997","unstructured":"Agus DB, Gambhir SS, Pardridge WM et al (1997) Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest 100:2842\u20132848. https:\/\/doi.org\/10.1172\/JCI119832","journal-title":"J Clin Invest"},{"key":"2516_CR165","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"2516_CR166","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/ptr.1553","volume":"18","author":"JC Tilak","year":"2004","unstructured":"Tilak JC, Banerjee M, Mohan H, Devasagayam TPA (2004) Antioxidant availability of turmeric in relation to its medicinal and culinary uses. Phytother Res 18:798\u2013804. https:\/\/doi.org\/10.1002\/ptr.1553","journal-title":"Phytother Res"},{"key":"2516_CR167","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1590\/S0074-02762001000500026","volume":"96","author":"CAC Ara\u00fajo","year":"2001","unstructured":"Ara\u00fajo CAC, Leon LL (2001) Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz 96:723\u2013728. https:\/\/doi.org\/10.1590\/S0074-02762001000500026","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2516_CR168","doi-asserted-by":"crossref","unstructured":"El-Seedi HR, Taher EA, Sheikh BY, et al (2018) Chapter 8 - hydroxycinnamic acids: natural sources, biosynthesis, possible biological activities, and roles in Islamic medicine. In: Atta-ur-Rahman (ed) Studies in Natural Products Chemistry. Elsevier, pp 269\u2013292","DOI":"10.1016\/B978-0-444-64068-0.00008-5"},{"key":"2516_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2019.152256","volume":"426","author":"L Qin","year":"2019","unstructured":"Qin L, Chen Z, Yang L et al (2019) Luteolin-7-O-glucoside protects dopaminergic neurons by activating estrogen-receptor-mediated signaling pathway in MPTP-induced mice. Toxicology 426:152256. https:\/\/doi.org\/10.1016\/j.tox.2019.152256","journal-title":"Toxicology"},{"key":"2516_CR170","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00044-019-02497-0","volume":"29","author":"OK Mahmood","year":"2020","unstructured":"Mahmood OK, Yasser MF (2020) Curcumin analogs: synthesis and biological activities. Med Chem Res 29:479\u2013486. https:\/\/doi.org\/10.1007\/s00044-019-02497-0","journal-title":"Med Chem Res"},{"key":"2516_CR171","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neulet.2016.10.050","volume":"636","author":"T Jaroonwitchawan","year":"2017","unstructured":"Jaroonwitchawan T, Chaicharoenaudomrung N, Namkaew J, Noisa P (2017) Curcumin attenuates paraquat-induced cell death in human neuroblastoma cells through modulating oxidative stress and autophagy. Neurosci Lett 636:40\u201347. https:\/\/doi.org\/10.1016\/j.neulet.2016.10.050","journal-title":"Neurosci Lett"},{"key":"2516_CR172","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.tips.2008.11.002","volume":"30","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Sung B (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30:85\u201394. https:\/\/doi.org\/10.1016\/j.tips.2008.11.002","journal-title":"Trends Pharmacol Sci"},{"key":"2516_CR173","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807\u2013818. https:\/\/doi.org\/10.1021\/mp700113r","journal-title":"Mol Pharm"},{"key":"2516_CR174","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","volume":"75","author":"A Goel","year":"2008","unstructured":"Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as \u201cCurecumin\u201d: from kitchen to clinic. Biochem Pharmacol 75:787\u2013809. https:\/\/doi.org\/10.1016\/j.bcp.2007.08.016","journal-title":"Biochem Pharmacol"},{"key":"2516_CR175","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.ejca.2005.05.009","volume":"41","author":"RA Sharma","year":"2005","unstructured":"Sharma RA, Gescher AJ, Steward WP (2005) Curcumin: the story so far. Eur J Cancer 41:1955\u20131968. https:\/\/doi.org\/10.1016\/j.ejca.2005.05.009","journal-title":"Eur J Cancer"},{"key":"2516_CR176","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/S0731-7085(96)02024-9","volume":"15","author":"Y-J Wang","year":"1997","unstructured":"Wang Y-J, Pan M-H, Cheng A-L et al (1997) Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15:1867\u20131876. https:\/\/doi.org\/10.1016\/S0731-7085(96)02024-9","journal-title":"J Pharm Biomed Anal"},{"key":"2516_CR177","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3164\/jcbn.40.92","volume":"40","author":"M Srinivasan","year":"2007","unstructured":"Srinivasan M, Sudheer AR, Menon VP (2007) Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr 40:92\u2013100. https:\/\/doi.org\/10.3164\/jcbn.40.92","journal-title":"J Clin Biochem Nutr"},{"key":"2516_CR178","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molmed.2012.01.004","volume":"18","author":"L Shen","year":"2012","unstructured":"Shen L, Ji H-F (2012) The pharmacology of curcumin: is it the degradation products? Trends Mol Med 18:138\u2013144. https:\/\/doi.org\/10.1016\/j.molmed.2012.01.004","journal-title":"Trends Mol Med"},{"key":"2516_CR179","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1074\/jbc.M110.178806","volume":"286","author":"M Griesser","year":"2011","unstructured":"Griesser M, Pistis V, Suzuki T et al (2011) Autoxidative and Cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin*. J Biol Chem 286:1114\u20131124. https:\/\/doi.org\/10.1074\/jbc.M110.178806","journal-title":"J Biol Chem"},{"key":"2516_CR180","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.molmed.2012.04.011","volume":"18","author":"ON Gordon","year":"2012","unstructured":"Gordon ON, Schneider C (2012) Vanillin and ferulic acid: not the major degradation products of curcumin. Trends Mol Med 18:361\u2013363. https:\/\/doi.org\/10.1016\/j.molmed.2012.04.011","journal-title":"Trends Mol Med"},{"key":"2516_CR181","unstructured":"Kaliora AC, Kanellos PT, Kalogeropoulos N Gallic (2013) Acid Bioavailability in Humans. 301\u2013312."},{"key":"2516_CR182","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/molecules23030695","volume":"23","author":"GR Velderrain-Rodr\u00edguez","year":"2018","unstructured":"Velderrain-Rodr\u00edguez GR, Torres-Moreno H, Villegas-Ochoa MA et al (2018) Gallic acid content and an antioxidant mechanism are responsible for the antiproliferative activity of \u2018ataulfo\u2019 mango peel on LS180 cells. Molecules 23:695. https:\/\/doi.org\/10.3390\/molecules23030695","journal-title":"Molecules"},{"key":"2516_CR183","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jfda.2016.05.003","volume":"24","author":"FA Khan","year":"2016","unstructured":"Khan FA, Maalik A, Murtaza G (2016) Inhibitory mechanism against oxidative stress of caffeic acid. J Food Drug Anal 24:695\u2013702. https:\/\/doi.org\/10.1016\/j.jfda.2016.05.003","journal-title":"J Food Drug Anal"},{"key":"2516_CR184","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/jn\/131.1.66","volume":"131","author":"MR Olthof","year":"2001","unstructured":"Olthof MR, Hollman PCH, Katan MB (2001) Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 131:66\u201371. https:\/\/doi.org\/10.1093\/jn\/131.1.66","journal-title":"J Nutr"},{"key":"2516_CR185","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ptr.3517","volume":"26","author":"C-X Tu","year":"2012","unstructured":"Tu C-X, Lin M, Lu S-S et al (2012) Curcumin inhibits melanogenesis in human melanocytes. Phytother Res PTR 26:174\u2013179. https:\/\/doi.org\/10.1002\/ptr.3517","journal-title":"Phytother Res PTR"},{"key":"2516_CR186","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1182\/blood-2006-12-065433","volume":"110","author":"N Boddaert","year":"2007","unstructured":"Boddaert N, Le Quan Sang KH, R\u00f6tig A et al (2007) Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 110:401\u2013408. https:\/\/doi.org\/10.1182\/blood-2006-12-065433","journal-title":"Blood"},{"key":"2516_CR187","doi-asserted-by":"publisher","unstructured":"Smith TJ, Ashar BH (2019) Iron Deficiency anemia due to high-dose turmeric. Cureus 11(1). https:\/\/doi.org\/10.7759\/cureus.3858","DOI":"10.7759\/cureus.3858"},{"key":"2516_CR188","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41420-019-0234-y","volume":"5","author":"NE Rainey","year":"2019","unstructured":"Rainey NE, Moustapha A, Saric A et al (2019) Iron chelation by curcumin suppresses both curcumin-induced autophagy and cell death together with iron overload neoplastic transformation. Cell Death Discov 5:150. https:\/\/doi.org\/10.1038\/s41420-019-0234-y","journal-title":"Cell Death Discov"},{"key":"2516_CR189","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.saa.2013.06.110","volume":"115","author":"I Kili\u00e7","year":"2013","unstructured":"Kili\u00e7 I, Ye\u015filo\u011flu Y (2013) Spectroscopic studies on the antioxidant activity of p-coumaric acid. Spectrochim Acta A Mol Biomol Spectrosc 115:719\u2013724. https:\/\/doi.org\/10.1016\/j.saa.2013.06.110","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"2516_CR190","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.tox.2005.09.011","volume":"217","author":"I Gulcin","year":"2006","unstructured":"Gulcin I (2006) Antioxidant activity of caffeic acid (3,4-dihydroxycinnamic acid). Toxicology 217:213\u2013220. https:\/\/doi.org\/10.1016\/j.tox.2005.09.011","journal-title":"Toxicology"},{"key":"2516_CR191","doi-asserted-by":"publisher","unstructured":"Hatcher HC, Singh RN, Torti FM, Torti SV (2009) Synthetic and natural iron chelators: therapeutic potential and clinical use. Future med chem. 1(9):1643\u20131670. https:\/\/doi.org\/10.4155\/fmc.09.121","DOI":"10.4155\/fmc.09.121"},{"key":"2516_CR192","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1001\/archneur.1991.00530240091029","volume":"48","author":"KF Swaiman","year":"1991","unstructured":"Swaiman KF (1991) Hallervorden-Spatz Syndrome and brain iron metabolism. Arch Neurol 48:1285\u20131293. https:\/\/doi.org\/10.1001\/archneur.1991.00530240091029","journal-title":"Arch Neurol"},{"key":"2516_CR193","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/archneur.1974.00490310072012","volume":"30","author":"EC Dooling","year":"1974","unstructured":"Dooling EC, Schoene WC, Richardson EP (1974) Hallervorden-Spatz Syndrome. Arch Neurol 30:70\u201383. https:\/\/doi.org\/10.1001\/archneur.1974.00490310072012","journal-title":"Arch Neurol"},{"key":"2516_CR194","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1046\/j.1440-1789.2003.00521.x","volume":"23","author":"H Miyajima","year":"2003","unstructured":"Miyajima H (2003) Aceruloplasminemia, an iron metabolic disorder. Neuropathology 23:345\u2013350. https:\/\/doi.org\/10.1046\/j.1440-1789.2003.00521.x","journal-title":"Neuropathology"},{"key":"2516_CR195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13317-016-0083-0","volume":"7","author":"GD Dalmazi","year":"2016","unstructured":"Dalmazi GD, Hirshberg J, Lyle D et al (2016) Reactive oxygen species in organ-specific autoimmunity. Autoimmun Highlights 7:1\u201311. https:\/\/doi.org\/10.1007\/s13317-016-0083-0","journal-title":"Autoimmun Highlights"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02516-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02516-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02516-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T20:23:45Z","timestamp":1637180625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02516-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":195,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["2516"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02516-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]},"assertion":[{"value":"16 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors have given final approval of this study and of the version submitted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}